Related Experiment Videos
The SLICC/ACR damage index: progress report and experience in the field
1University of Toronto, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.
Lupus
|November 24, 1999
Summary
The SLICC/ACR damage index assesses irreversible SLE damage from disease or treatment. It is validated for tracking patient outcomes and guiding clinical trials.
Area of Science:
- Rheumatology
- Clinical Epidemiology
Background:
- Systemic Lupus Erythematosus (SLE) causes cumulative organ damage.
- Assessing this damage is crucial for patient management and research.
Purpose of the Study:
- To describe the development and validation of the Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) damage index.
- To highlight its utility in SLE research and clinical practice.
Main Methods:
- Development of the SLICC/ACR damage index through expert consensus and data analysis.
- Validation of the index for reliability and clinical relevance.
Main Results:
- The SLICC/ACR damage index quantifies irreversible organ damage in SLE patients.
- The index has demonstrated validity and reliability for assessing long-term disease impact.
Conclusions:
- The SLICC/ACR damage index is a valuable tool for measuring accumulated damage in SLE.
- It is recommended for use as an outcome measure in longitudinal studies and clinical trials for SLE.